{"data":{"issuanceinfo":{"industrycode":"204005","industry":"醫療保健","ipoprice":{"ceiling":"1.200","floor":"1.200"},"ipodate":{"start":"2021-01-26 00:00:00","end":"2021-01-29 00:00:00"},"minimumcapital":"2424.18","subscribed":"22.47","marketcap":"10.72億","H_marketcap":"--","pe":"26.14","codesrate":"8.00","link":"https://staticpdf.iqdii.com/stockdata/notice/02161/2021/2021012600167_c.pdf","ipopricing":"1.200","resultdate":"2021-02-04 00:00:00","enddate":"2021-01-29 00:00:00","listeddate":"2021-02-05 00:00:00","issuenumber":"4468.60萬","issuenumberhK":"4468.60萬","issuenumberother":"--","grayprice":"1.37","sponsors":"中國銀河國際證券(香港)有限公司","raisemoney":"1060.00萬","use":"1、約47.2%或約5.0百萬港元為品牌中藥的產品組合開發及品牌管理提供資金；\n2、約43.4%或約4.6百萬港元為自第三方品牌擁有人獲取額外分銷權的付款提供資金；\n3、約9.4%或約1.0百萬港元補充我們的營運資金及用于一般企業用途。","shares":2000,"leadagent":"中國銀河國際證券(香港)有限公司,信達國際融資有限公司,艾德證券期貨有限公司,復星恒利證券有限公司,香江證券有限公司,邁時資本有限公司,西證(香港)證券經紀有限公司,TUS Corporate Finance Limited","bookrunners":"中國銀河國際證券(香港)有限公司","coordinator":"","firstDayOpen":"1.48","IsEiio":0,"Interestdays":6,"PENote":"按經審核的最近年度公司股東應占溢利和發行后總股本計算；發行價未確定時，按招股價中間價計算；發行價確定后，按招股定價計算。","OverAllotment":"--","StabilizingManager":"--","code":"E02161","name":"健倍苗苗","fullname":"健倍苗苗(保健)有限公司"},"institutioninfo":{"principaloffice":"香港九龍觀塘觀塘道388號創紀之城1期1座23樓2303-07室","registrars":"卓佳證券登記有限公司","registrarstel":"(852) 2980 1333","chairman":"岑廣業","secretary":"歐敏兒","telephone":"(852) 2267 2178","substantialshareholders":"JBM Group BVI(53.7%),Lincoln’s Hill(11.9%)","principalactivities":"公司主要從事制造及買賣品牌藥產品、健康保健品及品牌中藥。","website":"http://www.jbmhealthcare.com.hk"},"managerinfo":[{"managername":"岑廣業","post":"主席兼非執行董事","rankno":1},{"managername":"黃一偉","post":"行政總裁兼執行董事","rankno":2},{"managername":"朱家榮","post":"執行董事","rankno":3}],"investorinfo":[],"TotalShareholdingPercentage":0},"result":1,"Version":"4.5.190802.46408","ElapsedMilliseconds":7}